Browse Drug Recalls

13 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 13 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 13 FDA drug recalls.

Clear
DateProductReasonClassFirm
Oct 31, 2025 WeCare, Zinc Oxide Ointment, Net Wt. 15 oz/425 g, Manuactured for: Dynarex Co... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Dynagel, Moisturizing Wound Hydrogel, Net Wt. 3oz (84.7 g), Manufactured for:... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Globe Clotrimazole Cream USP, 1 % Antifungal Cream, Net Wt., 5 oz. (142 g, Di... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Nivagen, Zinc Oxide Ointment, Net Wt. 1 oz. (28.4g), Nivagen Pharmaceuticals,... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Lanashield Skin Barrier, 4 oz. (113 g), Manfuactured for: Dynarex Corporation... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Globe Clotrimazole Cream, USP, 1 %, Net Wt. 1 oz (28.4g), Distributed by: Tri... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Nivagen, Zinc Oxide Ointment USP, Zinc Oxide 20 %, Net Wt. 1 oz. (28.4g), Niv... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Dynashield, 4 oz cream (113 g), Manufactured for: Dynarex Corporation, 10 Gle... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporatio... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Wecare Enema, 4.5 Fl Oz/133mL, Manufactured for: Dynarex Corporation, 11 Dyn... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Dynashield Skin Protectant, Net Wt. 16 oz (453.6 g), Manufactured for: Dyrnar... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Nivagen Pharmaceuticals, Zinc Oxide Ointment USP, Zinc Oxide 20% Skin Protect... cGMP deviations Class II Blossom Pharmaceuticals
Oct 31, 2025 Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (5... cGMP deviations Class II Blossom Pharmaceuticals

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.